Endeavor

What Is Immunotherapy?

Harnessing the immune system to attack cancer gives patients new treatment options

Evaluating the Microbiome in Patients with Triple Negative Breast Cancer

Moffitt-led Pilot study looked at gut microbiome as biomarker for treatment response

The Long Journey in Search of a Cure

With one TIL therapy approved by the FDA, doctors push to optimize the treatment. Michelle Shannon is living for the next breakthrough.

Study Explores mRNA Vaccine Combo Therapy for Advanced Non-Small Cell Lung Cancer

Investigators study safety and efficacy of mRNA-based cancer vaccine combined with immunotherapy

FDA Set to Approve Earlier Use of CAR T for Multiple Myeloma

The treatment is currently approved for patients who fail four lines of treatment

Moffitt Expands TIL Therapy Research to Sarcoma Patients

Young sarcoma patients may benefit from tumor infiltrating lymphocyte therapy.

New Breakthrough Therapy for Metastatic Melanoma Receives FDA Approval

The personalized therapy uses a patient’s own immune cells to recognize and fight cancer

CAR T Effective as First-Line Therapy for High-Risk Lymphoma Patients

New three-year data from the phase 2 ZUMA-12 trial finds durable responses

FDA Investigating ‘Serious Risk’ of Malignancy After CAR T Therapy

Benefits of the treatment still outweigh its risks, experts say